1/74
Comprehensive 75-card vocabulary practice set covering clinical nursing judgment, prototype pharmacotherapy, fluid/electrolyte safety, gastrointestinal disorders (GERD/PUD), and anti-inflammatory mechanisms across Weeks 11, 12, and 13.
Water-Soluble Vitamins
Nutrients (B-complex and C) that dissolve easily in water and are absorbed directly across the digestive tract into the bloodstream; excess amounts are rapidly excreted in the urine rather than stored (except Vitamin B12, which is stored in the liver for years), resulting in a lower toxicity risk and necessitating daily dietary replenishment.
Fat-Soluble Vitamins
Lipid-soluble micronutrients (A, D, E, and K) that require dietary fat and bile salts for intestinal absorption, are stored in substantial quantities in the liver and adipose tissues, and carry a high risk of hypervitaminosis toxicity (especially A and D) because excess amounts accumulate in the body.
Vitamin A (Aquasol A)
A lipid-soluble retinoid prototype essential for bone and dental development, wound healing, epithelial integrity, and night vision pigment synthesis; prescribed at 30,000units/day for 1week for deficiency and strictly contraindicated in pregnancy at doses exceeding the RDA due to severe teratogenic birth defects.
Vitamin D (Ergocalciferol)
A lipid-soluble vitamin synthesized in the skin upon UV radiation exposure or obtained from fortified foods that regulates calcium and phosphate metabolism; deficiency results in rickets in children, osteomalacia in adults, and hypocalcemia, whereas toxic overdoses cause hypercalcemia and soft tissue calcification.
Vitamin E (Tocopherols)
A lipid-soluble primary antioxidant that protects plasma membranes against free-radical damage; deficiency in premature neonates triggers hemolytic anemia, and supplemental intake is strictly contraindicated during pregnancy without explicit healthcare provider approval.
Vitamin K (Phytonadione / K1 & K2)
A lipid-soluble vitamin essential for the hepatic biosynthesis of blood clotting factors II, VII, IX, and X and serving as the specific reversal agent for warfarin; routinely administered intramuscularly to newborns at birth because the neonatal gut is sterile and lacks clotting factor production.
Vitamin B1 (Thiamine)
A water-soluble coenzyme essential for carbohydrate metabolic pathways and peripheral nerve conduction; chronic alcohol use disorder represents the number one cause of its deficiency in the United States.
Beriberi
The severe deficiency disorder of Vitamin B1 (thiamine) manifested clinically by paresthesias, neuralgia, progressive loss of deep tendon reflexes, sensation impairment, muscle weakness, and foot drop, affecting both peripheral nervous and cardiovascular function.
Wernicke Encephalopathy Prevention Rule
The critical clinical rule requiring parenteral Vitamin B1 (thiamine) to be administered PRIOR to any intravenous glucose or dextrose infusions in patients with chronic alcohol use disorder to avoid precipitating acute, irreversible brain damage.
Vitamin B2 (Riboflavin)
A water-soluble vitamin that serves as a core component of coenzymes in oxidation-reduction metabolic reactions; deficiency results in corneal vascularization, anemia, and skin lesions, and therapeutic supplementation of 25 to 100mg/day typically turns the patient's urine bright yellow.
Vitamin B3 (Niacin)
A water-soluble vitamin required for cellular oxidative metabolism; high doses (up to 3g/day) utilized for hyperlipidemia trigger severe cutaneous flushing, pruritus, GI distress, and hepatotoxicity, which can be diminished by administering 320mg of aspirin 30minutes prior.
Pellagra
A progressive deficiency disease caused by lack of Vitamin B3 (niacin)—often related to alcoholism or corn-based diets—characterized by fatigue and anorexia followed by the classic advanced 3 Ds: dermatitis, diarrhea, and dementia.
Vitamin B6 (Pyridoxine)
A water-soluble vitamin essential for heme synthesis and amino acid metabolism; routine daily supplementation of 10–20mg/day is mandated for patients receiving isoniazid (INH) or hydralazine to prevent drug-induced peripheral sensory neuropathy.
Folic Acid (Vitamin B9)
A water-soluble B-complex prototype vitamin required for DNA synthesis, RBC maturation, and fetal neural development; deficiency produces megaloblastic anemia without the severe neurological sensory/motor degeneration seen in Vitamin B12 deficiency.
Vitamin B12 (Cyanocobalamin)
A water-soluble vitamin stored in the liver for several years that is critical for cell replication, erythrocyte maturation, and myelin synthesis; intestinal absorption requires gastric Intrinsic Factor and is diminished by proton pump inhibitors, metformin, and alcohol.
Pernicious Anemia
A megaloblastic anemia disorder caused by the absence of gastric Intrinsic Factor secondary to gastrectomy, gastric bypass, or autoimmune parietal cell destruction; manifests with a beefy red tongue (glossitis), paresthesias, ataxia, and requires lifelong monthly intramuscular injections of 1000mcg Vitamin B12.
Vitamin C (Ascorbic Acid)
A potent water-soluble antioxidant required for collagen synthesis, tissue repair, bone maintenance, and non-heme iron absorption; extreme excess dosing causes gastrointestinal distress, diarrhea, and the formation of renal calculi (kidney stones).
Scurvy
A connective tissue disorder caused by severe Vitamin C deficiency due to lack of fresh fruits/vegetables, cigarette smoking, or alcoholism; manifests with bleeding gums, gingivitis, petechiae, ecchymosis, impaired wound healing, and joint pain, treated with 300 to 1000mg/day.
Hypocalcemia
A serum calcium level below 8.8mEq/L resulting from Vitamin D deficiency, hypoparathyroidism, or chronic diarrhea; clinical manifestations include muscle twitching, cramping, hyperactive reflexes, spasms, tetany, and cardiac dysrhythmias, managed with slow intravenous calcium gluconate when severe.
Magnesium Sulfate (MgSO4)
An electrolyte and CNS depressant prototype drug indicated for severe hypomagnesemia (<1.4mEq/L) and eclamptic seizures; requires continuous cardiac monitoring, deep tendon reflex assessments, and serum magnesium checks every 6hours.
Calcium Gluconate
The emergency intravenous antidote administered immediately upon recognizing severe magnesium sulfate toxicity, signified by the loss of deep tendon reflexes, respiratory depression below 12breaths/min, severe hypotension, heart block, or circulatory collapse.
Potassium Safety Protocol
High-alert nursing safety directives dictating that IV potassium chloride must NEVER be administered via IV push or bolus (which causes immediate fatal cardiac arrest) and MUST be held if urine output drops below 30mL/hr (or <15mL/hr) due to extreme hyperkalemia risk.
Deferoxamine
The specific parenteral chelating antidote indicated for acute, potentially fatal pediatric iron poisoning, which otherwise causes gastrointestinal mucosal necrosis, metabolic acidosis, shock, and acute liver and heart failure.
Elemental (Monomeric) Enteral Formula
A lactose-free, very low-fat enteral feeding formulation (such as Vivonex T.E.N. or Criticare HN) containing free amino acids and simple sugars that can be absorbed directly across the intestinal wall without requiring endogenous pancreatic or brush-border digestive enzymes.
Enteral Feeding Drug-Binding Rule
The mandatory clinical timing protocol requiring enteral tube feedings to be held for 1 to 2hours before and 1 to 2hours after administering oral fluoroquinolones (ciprofloxacin) or warfarin to prevent formula minerals and proteins from inactivating or severely decreasing drug bioavailability.
Parietal Cells
Gastric epithelial secretory cells located in the stomach lining that secrete 1 to 3L/day of hydrochloric acid (HCl) to maintain a gastric juice pH of 1.5–3.5 and produce Intrinsic Factor, which is mandatory for the intestinal absorption of Vitamin B12.
Chief Cells
Gastric mucosal secretory cells that produce pepsinogen, an inactive proenzyme that is cleaved and activated by stomach hydrochloric acid into pepsin for dietary protein digestion.
Lower Esophageal Sphincter (LES)
A physiologic smooth muscle ring separating the esophagus from the stomach that normally prevents acidic gastric juices from refluxing upward; its incompetence or inappropriate relaxation is the primary defect in GERD.
Gastroesophageal Reflux Disease (GERD)
A digestive disorder characterized by the backflow of acidic gastric contents through an incompetent lower esophageal sphincter into the esophagus, causing pyrosis (heartburn), acid regurgitation, belching, and a sour taste.
Barrett's Esophagus
A serious premalignant complication developing in approximately 10% of patients with chronic, long-standing GERD, characterized by metaplastic cellular transformation of the esophageal epithelium that significantly elevates the risk of esophageal cancer.
Peptic Ulcer Disease (PUD)
An inflammatory condition characterized by circumscribed erosions within the mucosal lining of the stomach (gastric) or duodenum, primarily caused by Helicobacter pylori bacterial infection or NSAID-mediated mucosal injury.
Helicobacter pylori (H. pylori)
A gram-negative bacterium that adheres to GI mucosa and neutralizes surrounding acid, acting as the causative etiology for 90% of duodenal ulcers and 70–80% of gastric ulcers, which increases ulcer risk by 3.5-fold when combined with NSAID therapy.
Zollinger-Ellison Syndrome (ZES)
A rare clinical hypersecretory condition caused by a gastrin-producing neuroendocrine tumor (gastrinoma) in the pancreas or duodenum, leading to extreme hyperacidity and severe, persistent, recurrent peptic ulcerations.
Duodenal Ulcer
The most common form of peptic ulcer (80–90% of cases), typically occurring in males aged 30–50years, characterized by gnawing epigastric pain 1 to 3hours AFTER meals or during the night that is characteristically RELIEVED by eating food or taking antacids.
Gastric Ulcer
A peptic erosion of the stomach lining more common in females over 60years and heavily linked to NSAID use, characterized by burning epigastric pain that is AGGRAVATED by food intake, anorexia, nausea, and weight loss, having a higher risk of malignancy.
Gastrointestinal Perforation Triad
The life-threatening surgical emergency cue cluster consisting of sudden, severe, sharp epigastric pain radiating to the shoulder, a rigid, board-like abdomen with guarding, and absent bowel sounds.
Coffee-Ground Emesis
Vomitus containing dark brown, granular blood particles that have undergone partial chemical digestion by gastric hydrochloric acid, signifying an upper gastrointestinal bleeding episode.
Melena
Dark, black, tarry, foul-smelling stools resulting from the transit and bacterial degradation of digested hemoglobin, serving as a primary clinical marker of upper gastrointestinal hemorrhage.
Omeprazole (Prilosec)
A proton pump inhibitor (PPI) prototype that irreversibly binds to the H+/K+-ATPase enzyme system on parietal cells, blocking the final pathway of gastric acid secretion for up to 72hours.
Proton Pump Inhibitor Administration Timing
The critical administration protocol requiring omeprazole to be swallowed whole (never chewed, crushed, or opened) 20 to 30minutes BEFORE breakfast on an empty stomach to ensure peak drug concentrations coincide with food-activated proton pumps.
Proton Pump Inhibitor Long-Term Risks
Adverse outcomes associated with omeprazole therapy exceeding 2 to 3months, including impaired intestinal calcium absorption leading to osteoporosis and bone fractures, hypomagnesemia, atrophic gastritis, Clostridioides difficile infection, and hospital-acquired pneumonia.
Famotidine (Pepcid AC)
An H2-receptor antagonist prototype that competitively blocks histamine receptors on parietal cells, reducing the volume and hydrogen ion concentration of gastric secretions; prescribed once daily at bedtime for PUD and GERD.
H2-Receptor Antagonist CNS Toxicity
Central nervous system adverse effects—including acute confusion, disorientation, restlessness, hallucinations, and depression—that occur when famotidine crosses the blood-brain barrier, predominantly seen in elderly patients or those with Chronic Kidney Disease (CKD).
Famotidine Antacid Interaction
A pharmacologic drug-interaction rule dictating that antacids must NOT be administered within 1hour of famotidine, as concurrent antacid presence substantially decreases the GI absorption and clinical efficacy of the H2 blocker.
Aluminum Hydroxide (AlternaGEL)
An inorganic antacid prototype that chemically neutralizes existing stomach hydrochloric acid to raise gastric pH; notable for causing constipation, systemic phosphate depletion (hypophosphatemia), and being strictly contraindicated in suspected bowel obstruction.
Antacid Separation Rule
The nursing administration standard dictating that antacids like aluminum hydroxide must be scheduled at least 2hours BEFORE or 2hours AFTER other oral medications to prevent drug binding and impaired absorption.
Milk-Alkali Syndrome
A toxic metabolic syndrome resulting from the concurrent ingestion of calcium carbonate antacids with milk or high doses of Vitamin D, characterized by systemic hypercalcemia, headache, nausea, metabolic alkalosis, and acute kidney injury.
H. pylori Triple Therapy
The standard 7–14day first-line oral eradication regimen consisting of a Proton Pump Inhibitor (omeprazole) combined with two antibiotics: clarithromycin and amoxicillin (or metronidazole for penicillin-allergic patients).
Bismuth Subsalicylate
An agent used in quadruple therapy regimens for PUD that exerts direct antibacterial actions against Helicobacter pylori and inhibits the bacterium from adhering to the gastric epithelial mucosa.
GERD Head of Bed (HOB) Positioning Protocol
The non-pharmacologic intervention requiring elevation of the head of the bed 30∘ (or 6 to 8inches on bed blocks) to enlist gravity against nighttime acid reflux, avoiding extra pillows which bend the waist and elevate intra-abdominal pressure.
Acute vs. Chronic Inflammation
Acute inflammation is an immediate, self-limiting innate vascular defense that resolves in 8 to 10days upon foreign agent neutralization, whereas chronic inflammation is a slow-onset process persisting for months to years with continuous tissue destruction (e.g., RA, SLE, Crohn's).
Five Cardinal Signs of Inflammation
The classic clinical manifestations of localized tissue inflammation: Swelling (Tumor, from increased capillary permeability), Warmth (Calor, from hyperemic vasodilation), Redness (Rubor, from vascular congestion), Pain (Dolor, from nerve compression/bradykinin), and Loss of Function (Functio Laesa).
Histamine
A key chemical mediator stored in mast cells of epithelial tissues (skin, bronchial tree, GI tract, blood vessels) that initiates acute inflammation within seconds by causing rapid localized vasodilation and increased capillary permeability.
Anaphylaxis
A life-threatening medical emergency caused by widespread, systemic release of inflammatory mediators (primarily histamine), triggering profound vasodilation, fluid leakage, severe bronchospasm, shock, and hypotension; prioritized by airway management and epinephrine.
Cyclooxygenase-1 (COX-1)
A constitutive, protective enzyme present in all body tissues that reduces gastric acid production, increases cytoprotective stomach mucus, promotes renal blood flow, and promotes platelet aggregation via thromboxane synthesis.
Cyclooxygenase-2 (COX-2)
An inducible enzyme formed only after tissue injury occurs, responsible for synthesizing prostaglandins that trigger localized inflammation, pain receptor sensitization, tissue swelling, and hypothalamic fever elevation.
Three Core Therapeutic Effects of NSAIDs
The three primary pharmacological outcomes achieved by inhibiting cyclooxygenase: Analgesic (pain relief), Antipyretic (fever reduction), and Anti-inflammatory (suppression of tissue swelling).
NSAID Cardiovascular Black Box Warning
An FDA warning stating that non-aspirin NSAIDs significantly increase the risk of serious and potentially fatal cardiovascular thrombotic events, myocardial infarction, and stroke, rendering them strictly contraindicated for perioperative pain in Coronary Artery Bypass Graft (CABG) surgery.
NSAID Gastrointestinal Ulceration Mechanism
The process whereby nonselective NSAIDs inhibit the protective COX-1 enzyme, depleting gastric prostaglandins, reducing protective mucus and bicarbonate production, increasing stomach acid, and directly eroding the GI mucosa to cause peptic ulceration and fatal bleeding.
Aspirin (Acetylsalicylic Acid / ASA)
A salicylate prototype drug that irreversibly binds to and inhibits both COX-1 and COX-2 enzymes and platelet thromboxane, used for pain, fever, inflammation, and low-dose secondary/primary cardiovascular thrombotic prophylaxis.
Aspirin Platelet Lifespan Inhibition
The pharmacodynamic phenomenon wherein a single therapeutic dose of aspirin permanently and irreversibly inactivates platelet COX-1, terminating platelet thromboxane production and inhibiting aggregation for the cell's entire 8-to-11day lifespan.
Salicylism Syndrome
A pattern of acute or chronic salicylate toxicity resulting from high-dose aspirin, clinically identified by tinnitus (ringing in the ears), dizziness, headache, and profuse diaphoresis, requiring immediate drug discontinuation.
Reye Syndrome
A potentially fatal disorder causing acute encephalopathy and fatty liver failure that occurs when aspirin or salicylates are administered to children or adolescents under 19years of age suffering from viral illnesses such as influenza or chickenpox.
Aspirin Allergy Triad
A hypersensitivity reaction affecting approximately 1% of individuals—particularly prevalent in patients with asthma and nasal polyps—manifesting with severe bronchospasm, wheezing, dyspnea, and urticaria upon aspirin ingestion.
Ibuprofen (Advil, Motrin)
A nonselective NSAID prototype that reversibly inhibits COX-1 and COX-2 enzymes, indicated for arthritis, dysmenorrhea, pain, and fever with a maximum daily dosage ceiling of 3200mg/day, carrying black box warnings for fatal GI bleeding and CV thrombotic events.
Celecoxib (Celebrex)
A second-generation selective COX-2 inhibitor prototype that relieves pain and inflammation without inhibiting platelets or eroding GI mucosa, but carries a doubled risk of fatal MI/stroke and is used for osteoarthritis, rheumatoid arthritis, and FAP colorectal polyps.
Celecoxib Sulfonamide Contraindication
An absolute safety contraindication precluding the administration of celecoxib to any patient with a known allergy to sulfonamides ('sulfa' drugs) or who is undergoing perioperative CABG surgery.
Acetaminophen (Tylenol)
A centrally acting para-aminophenol derivative that acts directly on the hypothalamus to dilate peripheral vessels and produce heat dissipation and pain relief, without possessing any anti-inflammatory or antiplatelet properties.
Acetaminophen Acute Liver Failure Warning
A black box warning highlighting that excessive intake of acetaminophen (especially when combined with alcohol) is the leading cause of acute liver failure in the United States, prompting an FDA restriction limiting prescription combination tablets to 325mg.
N-Acetylcysteine (Acetadote)
The specific intravenous or oral antidote administered as early as possible following an acute acetaminophen overdose to supply glutathione precursors and neutralize hepatotoxic reactive metabolites.
Stevens-Johnson Syndrome (SJS)
A rare, life-threatening severe cutaneous adverse reaction associated with acetaminophen and other drugs, characterized by painful erythema, skin blistering, and peeling, demanding immediate and permanent medication discontinuation.
Prednisone
A synthetic systemic glucocorticoid prototype metabolized in the liver to active prednisolone that suppresses prostaglandin synthesis, inhibits phagocyte/lymphocyte infiltration, and inhibits histamine release for severe acute inflammation and asthma bronchospasm.
Cushing Syndrome (Corticosteroid-Induced)
A cluster of metabolic and physical adverse effects from overtreatment or prolonged corticosteroid therapy, including hyperglycemia, 'moon face', 'buffalo hump', central trunk obesity, osteoporosis, peptic ulcers, cataracts, and hypokalemia.
Corticosteroid Infection Masking
The clinical hazard whereby immunosuppression by prednisone simultaneously impairs host defenses and abolishes the classic hallmark signs of infection (such as fever and localized erythema), making active systemic infections a strict contraindication.
Adrenal Crisis & Mandatory Tapering
A life-threatening complication resulting from abrupt cessation of prednisone taken for longer than 10days, wherein adrenal cortex suppression causes acute vascular collapse, severe hypotension, and shock; prevented only by gradual dose tapering.